Englebert Financial Advisers LLC acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 1,993 shares of the healthcare conglomerate’s stock, valued at approximately $658,000.
A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Win Advisors Inc. acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $203,000. ABC Arbitrage SA purchased a new position in shares of UnitedHealth Group during the 4th quarter valued at approximately $306,000. KLCM Advisors Inc. lifted its position in shares of UnitedHealth Group by 6.0% during the 4th quarter. KLCM Advisors Inc. now owns 3,081 shares of the healthcare conglomerate’s stock valued at $1,017,000 after buying an additional 174 shares in the last quarter. Trek Financial LLC lifted its position in shares of UnitedHealth Group by 8.8% during the 4th quarter. Trek Financial LLC now owns 753 shares of the healthcare conglomerate’s stock valued at $248,000 after buying an additional 61 shares in the last quarter. Finally, AG2R LA Mondiale Gestion D Actifs lifted its position in shares of UnitedHealth Group by 5.6% during the 4th quarter. AG2R LA Mondiale Gestion D Actifs now owns 36,052 shares of the healthcare conglomerate’s stock valued at $11,901,000 after buying an additional 1,920 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.
UnitedHealth Group Stock Up 1.2%
Shares of UNH opened at $384.40 on Tuesday. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $387.21. The company has a market capitalization of $349.09 billion, a PE ratio of 29.03, a price-to-earnings-growth ratio of 1.64 and a beta of 0.64. The stock has a fifty day simple moving average of $308.40 and a two-hundred day simple moving average of $317.22. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 0.69.
UnitedHealth Group Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th were paid a $2.21 dividend. The ex-dividend date of this dividend was Monday, March 9th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.3%. UnitedHealth Group’s dividend payout ratio (DPR) is 66.77%.
Wall Street Analyst Weigh In
A number of brokerages have recently issued reports on UNH. Raymond James Financial upgraded UnitedHealth Group from a “market perform” rating to an “outperform” rating and set a $330.00 target price on the stock in a research report on Wednesday, April 1st. UBS Group decreased their price objective on UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating on the stock in a report on Wednesday, January 28th. Mizuho decreased their price objective on UnitedHealth Group from $430.00 to $350.00 and set an “outperform” rating on the stock in a report on Thursday, February 5th. Argus upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $400.00 price objective on the stock in a report on Wednesday, April 22nd. Finally, Royal Bank Of Canada raised their price objective on UnitedHealth Group from $361.00 to $400.00 and gave the company an “outperform” rating in a report on Wednesday, April 22nd. One investment analyst has rated the stock with a Strong Buy rating, twenty have given a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $378.88.
Read Our Latest Research Report on UNH
Insider Activity
In related news, CEO Patrick Hugh Conway sold 800 shares of the firm’s stock in a transaction dated Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total transaction of $284,000.00. Following the completion of the sale, the chief executive officer directly owned 17,805 shares of the company’s stock, valued at approximately $6,320,775. This trade represents a 4.30% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.28% of the stock is owned by company insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
